Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Subsequently, the average signal values among the Control, Galactose, and Glutamate samples were calculated, and the genes whose expression levels increased more than two-fold from the Control to Galactose and decreased more than 1.5-fold from Galactose to Glutamate were extracted
Secondary outcomes The secondary outcomes are as follows: type 2 diabetes, glucose, HbA1c, insulin, lipid profile (LDL-cholesterol, HDL-cholesterol, triglycerides and apolipoprotein B), systolic blood pressure, diastolic blood pressure, and body mass index (BMI), which are well-established risk factors for CVD in clinical practice, or recently identified to be related to CVD in MR, such as apolipoprotein B [30, 31]
The longer-term benefit of improving cardiovascular risk is a longer journey
& Pisetsky, D
US$ 24.00
US$ 20.56
US$ 29.30
US$ 26.14
US$ 26.37
